We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
6 hedge funds and large institutions have $194K invested in Windtree Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
2% less capital invested
Capital invested by funds: $198K → $194K (-$3.59K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$37.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$37K |
Top Sellers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.29K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$190 |